Literature DB >> 34473674

Variably Protease-sensitive Prionopathy in a Middle-aged Man With Rapidly Progressive Dementia.

Juebin Huang1, Mark Cohen2, Jiri Safar2, Alexander P Auchus1.   

Abstract

Variably protease-sensitive prionopathy (VPSPr) is a recently described sporadic prion disease with distinctive clinical and histopathological features. We report the clinical, imaging, and neuropathological features of VPSPr in a 46-year-old right-handed man who presented with progressive cognitive decline, behavior disturbances, and a 50-pound weight loss over 6 months. The initial evaluation revealed severe cognitive impairment with no focal neurologic deficits. His cognitive, psychiatric, and behavior symptoms progressed rapidly, and he died 12 months after the initial visit. Throughout his disease course, workup for rapid progressive dementia was unremarkable except that brain MRI diffusion-weighted imaging showed persistent diffuse cortical and thalamic signal abnormalities. Sporadic Creutzfeldt-Jakob disease was highly suspected; however, two EEGs (8 months apart) demonstrated only nonspecific cerebral dysfunction. The patient's CSF 14-3-3 protein was negative at the initial visit and again 8 months later. His CSF real-time quaking-induced conversion and total tau level were normal. An autopsy of his brain was performed, and the neuropathological findings confirmed VPSPr. Our case underlines the importance of considering VPSPr in the spectrum of prion disease phenotypes when evaluating individuals with rapidly progressive dementia.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34473674      PMCID: PMC8803003          DOI: 10.1097/WNN.0000000000000276

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.590


  21 in total

1.  Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, α synuclein and Aβ pathology.

Authors:  Mark W Head; Suzanne Lowrie; Gurjit Chohan; Richard Knight; David J Scoones; James W Ironside
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

2.  A case of protease sensitive prionopathy in a patient in the UK.

Authors:  M W Head; R Knight; M Zeidler; H Yull; A Barlow; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-07       Impact factor: 8.090

Review 3.  Prion Disease.

Authors:  Kelly J Baldwin; Cynthia M Correll
Journal:  Semin Neurol       Date:  2019-09-18       Impact factor: 3.420

Review 4.  Clinical update of Jakob-Creutzfeldt disease.

Authors:  Mee-Ohk Kim; Michael D Geschwind
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

5.  Variably protease-sensitive prionopathy: a novel disease of the prion protein.

Authors:  Pierluigi Gambetti; Gianfranco Puoti; Wen-Quan Zou
Journal:  J Mol Neurosci       Date:  2011-05-17       Impact factor: 3.444

Review 6.  Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.

Authors:  Mark W Head; Helen M Yull; Diane L Ritchie; Jan P Langeveld; Nicholas A Fletcher; Richard S Knight; James W Ironside
Journal:  Brain       Date:  2013-04       Impact factor: 13.501

Review 7.  Variably protease-sensitive prionopathy: A differential diagnostic consideration for dementia.

Authors:  Stella H Kim; Melissa M Yu; Adriana M Strutt
Journal:  Neurol Clin Pract       Date:  2019-04

8.  Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case report.

Authors:  Ana B Rodríguez-Martínez; Adolfo López de Munain; Isidro Ferrer; Juan J Zarranz; Begoña Atarés; Nuria T Villagra; Jose M Arteagoitia; Joseba M Garrido; Ramón A Juste
Journal:  J Med Case Rep       Date:  2012-10-11

9.  Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum.

Authors:  Mikel Vicente-Pascual; Marcello Rossi; Josep Gámez; Albert Lladó; Josep Valls; Oriol Grau-Rivera; Rainiero Ávila Polo; Franc Llorens; Inga Zerr; Isidre Ferrer; Carlos Nos; Piero Parchi; Raquel Sánchez-Valle; Ellen Gelpí
Journal:  Ann Clin Transl Neurol       Date:  2018-09-21       Impact factor: 4.511

10.  Variably protease-sensitive prionopathy mimicking frontotemporal dementia.

Authors:  Miren Aizpurua; Sashika Selvackadunco; Helen Yull; Christopher M Kipps; James W Ironside; Istvan Bodi
Journal:  Neuropathology       Date:  2019-03-07       Impact factor: 1.906

View more
  1 in total

1.  Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.

Authors:  Bryce K Chang; Gregory S Day; Jonathan Graff-Radford; Andrew McKeon; Eoin P Flanagan; Alicia Algeciras-Schimnich; Michelle M Mielke; Aivi Nguyen; David T Jones; Michel Toledano; Walter K Kremers; David S Knopman; Ronald C Petersen; Wentao Li
Journal:  Eur J Neurol       Date:  2022-07-05       Impact factor: 6.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.